More on PFSA

- Summary
- Chart
- Profile
- Historical

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

profusa (NQ:PFSA)
Delayed: 0.96 +0.02 (2.13%)
Prev. Close $0.94  
Open$0.92 
52 Wk High$ 
52 Wk Low$ 
Day High$0.98 
Day Low$0.91 
P/E N/A  
EPS$ 
Volume51,083 

Friends, Peers and Foes (?): NVAC QUCY (more...)

Jul 31, 2026 05:15 PM Profusa signs option to acquire diagnostics firm G3 Vision Labs
Jul 31, 2026 05:15 PM Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs
Jul 27, 2026 06:00 AM Profusa signs term sheet to acquire diagnostics firm with $111M revenue
Jul 27, 2026 06:00 AM Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company
Jul 2, 2026 11:00 AM Profusa executes 1-for-25 reverse stock split on Nasdaq
Jul 2, 2026 11:00 AM Profusa Announces 1-for-25 Reverse Stock Split
Jun 24, 2026 08:00 AM Profusa shareholders approve acquisition and Nasdaq compliance measures
Jun 24, 2026 08:00 AM Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
Jun 12, 2026 08:00 AM Profusa submits response to European regulator for Lumee device review
Jun 12, 2026 08:00 AM Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform
View All Articles

Entities mentioned with PFSA

View All Entities